MENU

INSIGHTS

Molekule partners with a range of clients on an array of strategic and tactical engagements – every engagement is unique, and so is our approach. We specialize in crafting bespoke solutions for our clients based on their unique requirements.

See below case studies from some of our recent engagements with our clients as examples of what our clients have been able to accomplish in partnership with us.

Case Studies

Top-10 Innovator MNC Biopharma
Top-5 MNC Innovator Pharma
Specialty Biopharma
Major EU Biopharma
Top-3 MNC Biopharma
Boutique Biotech
Product Protection Department at Leading Japanese Pharma

Timeline Overview

3 Year Longitudinal Competitive Intelligence Outcomes from Therapy Area X
Date Reported to client
Date Intelligence materialized
1
Competitor X to unveil and leverage new global marketing campaign at key global therapy area conference
2
Competitor Y will initiate broad range of label extension and lifecycle management (“LCM”) clinical trials
3
Competitor C to re-organize field support of blockbuster brand L, reducing sales rep headcount while increasing MSL and KAM resourcing driving a “softer sell” of brand L
4
Competitor R to develop aggressive follow-on molecules in “therapy area X portfolio approach” via both in-house R&D and licensed molecule approach
5
EMA and PMDA to favorably respond to competitor P’s MAA and NDA, respectively, enabling competitor P to launch product M in 3Q’18 (EU) and
2Q’19 (Japan)
6
Competitor R to develop
novel, co-formulated dual moiety biologic pipeline therapy leveraging high potential proprietary academia and biotechnology partnership

Explore some of our latest thinking

Harnessing Market Disruption in the Era of CAR T: Brand Maximization Opportunities and Challenges in DLBCL
Learn More

Client testimonials

Associate Director
Associate Director
Director
Senior Manager
Senior Director
"It takes a lot of coordination and effort to drive home consistency and quality in terms of high impact deliverables and high quality, accurate and precise intelligence. The folks over at Molekule Consulting have an amazing ability to do that time in and time out."
Global Commercial Strategy,
MNC Biopharmaceutical Company
"I must compliment Molekule [Consulting] on their ability to develop sources and track down individuals, globally, who are difficult-to-reach. As a firm, Molekule [Consulting] can develop some of the best primary [competitive intelligence] out there and they synthesize it quite well. Their deliverables are well refined and to the point of a ‘MBB-style’ consultancy."
Global Commercial Strategy,
MNC Biopharmaceutical Company
“The dedication and real, two-way communication between the Molekule team and us was stellar - and helped better fulfill the engagement objectives. Communication is key in any services industry - even down to the consultancy level - and they knocked it out of the park in terms of the intelligence and deliverables - when you get that synergized with the communication, it is great!”
Competitive Strategic Insights,
Top-10 Biotech
“Wargaming may no longer be politically correct – but let us be true – it is a war game. Strategy workshops conducted by Molekule [Consulting] are standout – they are well prepared and facilitated. The level of engagement with our internal key stakeholders was extremely good and the key take-homes were solid. Overall, I was very impressed with the job the Molekule group did and would definitely re-engage with them”
Top 5 Global
Pharmaceutical Company
“There are few and far between [competitive intelligence] agencies that do the job ethically and right - collecting solid intelligence findings and reporting it properly, strategically and actionably. Molekule [Consulting] does just that - after 23 years in the industry on the client-side, inside the walls of Pharma, I can wholeheartedly endorse the Molekule [Consulting] team.”
Global Competitive Intelligence,
Major Pharma
“I must compliment Molekule [Consulting] on their ability to develop sources and track down individuals, globally, who are difficult-to-reach. As a firm, Molekule [Consulting] can develop some of the best primary [competitive intelligence] out there and they synthesize it quite well. Their deliverables are well refined and to the point of a ‘MBB-style’ consultancy.”
Global Commercial Strategy,
MNC Biopharmaceutical Company

Top-10 Innovator MNC Biopharma

Situation
Our client faced near-term direct competition from both generic and novel FDC HIV ARV assets.
Action
In support of a Top-10 innovator MNC biopharma player, Molekule conducted a comprehensive landscape monitoring of the HIV market for FDC ARV generics – either direct ANDA competitors to established brands or novel FDCs of generics components. We worked with a Director of Strategic Planning to assess the impact and implications of generic threats to established ARV agents, as well as novel FDC ARV agents.
Results
Our client sought high value antibiotic targets for in-licensing, acquisition and/or partnership.
Molekule conducted comprehensive landscape monitoring inclusive of:
Congress Coverage
KOL Interviews
Competitor Interviews
Payer Interviews
Regulatory Stakeholder Interviews

Specialty Biopharma

Situation
Our client was engaged in the highly competitive IBD space and needed a focused and robust universe of KIT/Qs answered to better address emerging competitive dynamics.
Action
Molekule furnished our client high impact, accurate, timely and actionable strategic insight and intelligence leveraging congresses as venues flush with high value human sources resulting in our client hardening competitive pinch points and elucidating blind spots.
Results
Molekule was engaged by a specialty gastroenterology player to conduct comprehensive congress coverage of the UEGW and ACG congresses in support of a blockbuster anti-TNF asset. Our client was a Senior Manager of Global Competitive Intelligence. Engaging together, Molekule depicted clear answers to the client’s high, medium and low priority KIT/Qs, enabling the client company to position itself for robust success in the gastroenterology space, forward-looking in the U.S. and EU.
Molekule was engaged to conduct comprehensive congress coverage inclusive of:
Congress Coverage
KOL Interviews
Competitor Interviews

Major EU Biopharma

Situation
Our client wanted to understand competitive commercial strategies across global mid-sized biopharmaceutical players.
Action
Partnering together, Molekule and client developed keen insights and market intelligence regarding middle market capitalization competitors’ global market access and go-to-market access strategies, worldwide.
Results
Molekule was engaged by a large cap EU-based biopharmaceutical player to conduct a targeted assessment of novel strategic implementation models across mid-sized (i.e.-$300MM – $750MM market capitalization) biopharmaceutical players’ approaches to global market access and go-to-market strategy. Our client was a Senior Director of Marketing Analytics and Business Insights.
Molekule was engaged to conduct a targeted market access & go-to-market strategy assessment inclusive of:
Congress Coverage
KOL Interviews
Internal Stakeholder Interviews
cross
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram